文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Tumor immunotherapy directed at PD-1.

作者信息

Ribas Antoni

出版信息

N Engl J Med. 2012 Jun 28;366(26):2517-9. doi: 10.1056/NEJMe1205943. Epub 2012 Jun 2.

DOI:10.1056/NEJMe1205943
PMID:22658126
Abstract
摘要

相似文献

[1]
Tumor immunotherapy directed at PD-1.

N Engl J Med. 2012-6-28

[2]
Progress in immunotherapy of cancer.

N Engl J Med. 2012-9-20

[3]
Haematological cancer: PD-1 blockade: opening the door to attack.

Nat Rev Clin Oncol. 2015-2

[4]
Words of wisdom. Re: Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

Eur Urol. 2015-4

[5]
Programmed death protein 1 inhibitors making inroads in multiple cancers.

J Natl Cancer Inst. 2015-5-9

[6]
Mismatch Repair-Deficient Cancers Are Targets for Anti-PD-1 Therapy.

Cancer Cell. 2015-7-13

[7]
[Clinical pharmacology and immunotherapy, 4th edition of the congress of pharmacology of anticancer drugs].

Bull Cancer. 2017-9

[8]
PD-1/PD-L1 and immunotherapy for pancreatic cancer.

Cancer Lett. 2017-8-18

[9]
Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment.

Clin Microbiol Infect. 2018-3

[10]
Immuno-oncology moves beyond PD-1.

Nat Biotechnol. 2015-7

引用本文的文献

[1]
Role of Human Microbiome in Development and Management of Head and Neck Squamous Cell Carcinoma.

Cancers (Basel). 2025-7-3

[2]
Spatial heterogeneity of PD-L1 expression influence its assessment in esophageal squamous cell carcinoma.

Transl Oncol. 2025-6-12

[3]
Pembrolizumab-Associated Acute Esophageal Necrosis: A Case Report and Literature Review.

HCA Healthc J Med. 2025-4-1

[4]
Cancer chemoprevention: signaling pathways and strategic approaches.

Signal Transduct Target Ther. 2025-4-18

[5]
Mechanisms of Resistance to Anti-PD-1 Immunotherapy in Melanoma and Strategies to Overcome It.

Biomolecules. 2025-2-12

[6]
Enhancing cancer care with improved checkpoint inhibitors: a focus on PD-1/PD-L1.

EXCLI J. 2024-10-29

[7]
Integration of transcriptomics and machine learning for insights into breast cancer: exploring lipid metabolism and immune interactions.

Front Immunol. 2024

[8]
Locoregional therapies combined with immune checkpoint inhibitors for liver metastases.

Cancer Cell Int. 2024-8-31

[9]
Receptors and Signaling Pathways Controlling Beta-Cell Function and Survival as Targets for Anti-Diabetic Therapeutic Strategies.

Cells. 2024-7-24

[10]
Treatment of intracranial inflammatory myofibroblastic tumor with PD-L1 inhibitor and novel oncolytic adenovirus Ad-TD-nsIL12: a case report and literature review.

Front Immunol. 2024-7-24

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索